Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study (Q42663299)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2005
edit
Language Label Description Also known as
English
Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study
scientific article published on July 2005

    Statements

    Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study (English)
    Marc I Lorber
    Shamkant Mulgaonkar
    Khalid M H Butt
    Elmahdi Elkhammas
    Robert Mendez
    P R Rajagopalan
    Barry Kahan
    Nathalie Cretin
    Helio Tedesco
    B251 Study Group
    244-252

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit